pfizer glp 1 drug Danuglipron: Pfizer's GLP-1 receptor agonist weight loss pill ADA '26: Lilly's dominance, Pfizer's

Description

After the Icelandic Medicines Agency published initial safety concerns in July 2023, regulatory bodies worldwide have launched investigations to assess the potential risk of suicidality among GLP-1 receptor agonist users

Maybe you have not tried these medications due to fear of muscle loss, getting Ozempic face, dependence on the medications, preference to maintain a healthy weight organically or simply due to cost

Intestinal and brain cells contain prohormone convertase 1 (PC1), which is able to cleave proglucagon into Glicentin, Oxyntomodulin, GLP-1, GLP-2 and IP-2, while pancreatic islet cells contain prohormone convertase 2 (PC2), which capable of cleaving proglucagon into Glucagon and MPGF

Key components include resistance training and daily moderate aerobic exercise, adequate high-quality protein intake (1.21.6 g/kg adjusted body weight/day) distributed evenly across meals, micronutrient supplementation, and periodic reassessment of lean mass via DXA, BIA or functional outcomes (e.g., handgrip strength and gait speed) to optimize fat loss while minimizing sarcopenia risk (Table 2)